US FDA News: Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Second COVID-19 Vaccine Candidate

FDA has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 17, 2020 to discuss Moderna’s emergency use authorization request for a COVID-19 vaccine.
Read more: Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Second COVID-19 Vaccine Candidate

Pharma Reviews: Mankind Pharma announces megastar Mohanlal as their corporate brand ambassador

Thiruvananthapuram, Nov 30 (UNI) India's leading pharmaceutical company Mankind Pharma has announced Malayalam megastar Mohanlal as their ...
Read more: Mankind Pharma announces megastar Mohanlal as their corporate brand ambassador

Pharma Reviews: 'Finland can Help India's Digital Push'

Even before the pandemic, there was industrial cooperation in the pharma sector between the two countries. India's role is very important globally.
Read more: 'Finland can Help India's Digital Push'

Pharma Reviews: INTERVIEW | Finland can help India's digital push: Ambassador Ritva Koukku-Ronde

India's role is very important globally. The Finnish pharma industry is using raw materials and medicines from India. What's the plan to boost tourism from ...
Read more: INTERVIEW | Finland can help India's digital push: Ambassador Ritva Koukku-Ronde

Pharma Reviews: Financing India: Swedish companies in India already committed to invest USD 1 billion in coming ...

Anantha Padmanabhan, Managing Director India, Alfa Laval: Energy and its conservation; manufacturing in pharma; petrochemicals and chemicals ...
Read more: Financing India: Swedish companies in India already committed to invest USD 1 billion in coming ...

Pharma Reviews: LIVE| Govt offices with Grade 1 officers shall function with 100% strength: DDMA

... has agreed to make 100 million doses of its Covid-19 vaccine Sputnik V in collaboration with the Indian pharmaceutical company Hetero in India.
Read more: LIVE| Govt offices with Grade 1 officers shall function with 100% strength: DDMA

Pharma Reviews: Serum Institute says in active talks with Indian government around potential COVID-19 vaccines

Serum Institute of India (SII) is in active discussions with the Indian ... 1994, is today India's leading business fortnightly for the pharmaceutical industry.
Read more: Serum Institute says in active talks with Indian government around potential COVID-19 vaccines

Pharma Reviews: Surge in cyber attacks on Indian vaccine makers in Oct-Nov: Report

Attackers have also targeted the medical manufacturing sector's billing ... at least seven Indian pharma companies are working to develop a vaccine ...
Read more: Surge in cyber attacks on Indian vaccine makers in Oct-Nov: Report

Pharma Reviews: AstraZeneca, RSSDI ink pact for empowering 1 crore Indian Diabetic patients by 2023

Bangalore: AstraZeneca India (AstraZeneca Pharma India Limited), a science-led biopharmaceutical company, has recently signed a memorandum of ...
Read more: AstraZeneca, RSSDI ink pact for empowering 1 crore Indian Diabetic patients by 2023

Pharma Reviews: Pharma companies likely to attain normalcy this quarter; October sees bumper rise in sales

Indian pharmaceutical market grew 1 per cent on-year in Q2 FY21, against a fall of 5.9 per cent in the first quarter, said a report by India Ratings.
Read more: Pharma companies likely to attain normalcy this quarter; October sees bumper rise in sales

Pharma Reviews: Vital vials: A look at how COVID-19 vaccines will be stored

The major companies making vials in India include Schott Kaisha, Saint ... Borosilicate glass is considered “the gold standard” for packaging drugs.
Read more: Vital vials: A look at how COVID-19 vaccines will be stored

Pharma Reviews: Riding the Vaccine Wave

These are areas where Indian pharma companies' past is riddled with failure. ... Will vaccines help Indian generic pharmaceutical industry build their ...
Read more: Riding the Vaccine Wave

Pharma Reviews: Sensex, Nifty end lower in choppy trade; broader indices outperform

Hetero Drugs to produce over 100 mln doses/year of Sputnik V vaccine in India. Pharmaceutical firm Hetero Group will manufacture over 100 million ...
Read more: Sensex, Nifty end lower in choppy trade; broader indices outperform

Pharma Reviews: Pharma Growth in October 2020 at 7-Month High: Ind-Ra

Indian pharmaceuticals market (IPM) in October 2020 grew 9.6%, which is the highest in the past seven months. This growth was led by volume ...
Read more: Pharma Growth in October 2020 at 7-Month High: Ind-Ra

Pharma Reviews: Rising claims: Insurers may increase prices, but drug prices may not be affected

Pharmaceutical companies are likely to see another round of price increase in 2021. ... in claims globally in the pharma sector, and, hence, this translates to Indian ... A senior pharma executive, who is into the manufacturing of Active ...
Read more: Rising claims: Insurers may increase prices, but drug prices may not be affected

Pharma Reviews: Making access to quality medicine truly inclusive: The need to go beyond urban India

India – Largest Manufacturer of Generic Drugs. Indian Pharmaceutical industry is the 3rd largest globally in volume, and the largest supplier of generic ...
Read more: Making access to quality medicine truly inclusive: The need to go beyond urban India

Pharma Reviews: Market LIVE: Trade choppy; Sensex down 100 points, Nifty below 12850

AstraZeneca Pharma India down as parent admits error in vaccine manufacturing. AstraZeneca and Oxford University on Wednesday acknowledged a ...
Read more: Market LIVE: Trade choppy; Sensex down 100 points, Nifty below 12850

US FDA News: Coronavirus (COVID-19) Update: FDA Issues New Policy on Dry Heat for Reuse of Certain Respirators

The FDA issued guidance on the use of dry heat for bioburden reduction to help support the single-user reuse of certain particulate filtering facepiece respirators (FFRs), such as N95 respirators, by health care personnel when there is a limited supply during the COVID-19 public health emergency.
Read more: Coronavirus (COVID-19) Update: FDA Issues New Policy on Dry Heat for Reuse of Certain Respirators

Pharma Reviews: Ind-Ra expects Indian two-wheeler exports to see sustained growth in H2FY22

Ind-Ra expects Indian two-wheeler exports to see sustained growth in H2FY22 ... Indian two-wheeler manufacturers like Bajaj Auto and TVS Motor will be ... Indian Pharma major, Alembic Pharmaceuticals informed the bourses on ...
Read more: Ind-Ra expects Indian two-wheeler exports to see sustained growth in H2FY22

Pharma Reviews: Stock Market Highlights: Sensex, Nifty fall from record highs to end 1.5% lower; financials drag

Stock Market Highlights: The Indian indices fell from record-high levels to end 1.5 percent lower ... Nifty Pharma was the top laggard, down 2 percent.
Read more: Stock Market Highlights: Sensex, Nifty fall from record highs to end 1.5% lower; financials drag

Pharma Reviews: Indian pharma exports may cross $25 billion in 2020-21

Indian pharmaceutical industry is growing leaps and bounds, it seems. Ravi Uday Bhaskar, Director General of Pharmaceutical Export Council of India ...
Read more: Indian pharma exports may cross $25 billion in 2020-21

Pharma Reviews: Share Market News Live: Sensex down 700 points, Nifty at 12850; Kotak Bank, Airtel, Sun Pharma ...

India Stock Market News Updates Today: Global equities were mostly buoyed today encouraged by news on the development of coronavirus vaccines ...
Read more: Share Market News Live: Sensex down 700 points, Nifty at 12850; Kotak Bank, Airtel, Sun Pharma ...

Pharma Reviews: 'China plus one' strategy prompting global firms to invest in India: Utpal Oza, Nomura

... the Indian pharma sector has become a big target for private equity funds. ... for local companies to move production facilities as well as India's own ...
Read more: 'China plus one' strategy prompting global firms to invest in India: Utpal Oza, Nomura

US FDA News: Coronavirus (COVID-19) Update: November 24, 2020

Coronavirus (COVID-19) Update
Read more: Coronavirus (COVID-19) Update: November 24, 2020

Pharma Reviews: Indian pharma companies take coronavirus ride; production of anti-malarial drugs shoot up 334%

The production of anti-malarial drugs rose by a record 334.3 per cent from Rs 5.4 crore in H1 FY20 to Rs 21.9 crore in H1 FY21. pharma industry ...
Read more: Indian pharma companies take coronavirus ride; production of anti-malarial drugs shoot up 334%

Pharma Reviews: Balancing supply chain has been greatest challenge during COVID-19: med device experts

Medical device manufacturers have not escaped the pandemic's impact. The Indian medical devices market which was supposed to grow to $50 billion ...
Read more: Balancing supply chain has been greatest challenge during COVID-19: med device experts

Pharma Reviews: Stock Market Live: Sensex at day's high, Nifty above 13000; banks, auto stocks drive rally

Stock Market Live: Indian indices were trading at record-high levels on Tuesday ... #CNBCTV18Market | Pharma stocks move higher pic.twitter.com/ ...
Read more: Stock Market Live: Sensex at day's high, Nifty above 13000; banks, auto stocks drive rally

Pharma Reviews: Role of Indian pharma will likely grow under the Biden administration

It has long been known that America alone accounts for nearly 50 per cent of the world's pharmaceutical market and thus it becomes even more ...
Read more: Role of Indian pharma will likely grow under the Biden administration

Pharma Reviews: India's overall spending on health sector 'low', says Niti Aayog member VK Paul

India's overall spending on the health sector is "low" and the situation must be ... In 2018-19, India's spending on health sector was 1.5 per cent of GDP, ... medical seats and a 79 per cent increase in post graduate medical seats.
Read more: India's overall spending on health sector 'low', says Niti Aayog member VK Paul

Pharma Reviews: Entire world looking at India for affordability, volume of Covid vaccine: Ravi Uday Bhaskar

Pharmaceuticals Export Promotion Council of India's Director General, Ravi Uday Bhaskar on Monday said that pharmaceutical exports are doing well, ...
Read more: Entire world looking at India for affordability, volume of Covid vaccine: Ravi Uday Bhaskar

Pharma Reviews: Govt keen to support Industrial parks for API, Pharma & nutraceuticals

This way, he said, Indian pharma industry will continue to play a prominent role as the pharmacy of the world. “We are also encouraging innovation in ...
Read more: Govt keen to support Industrial parks for API, Pharma & nutraceuticals

Pharma Reviews: Stock Market Highlights: Sensex ends 195 points higher, Nifty holds 12900; IT, energy stocks surge

Stock Market Highlights: Indian indices ended higher on Monday helped by gains in IT ... We expect the pharma sector to again resume its momentum.
Read more: Stock Market Highlights: Sensex ends 195 points higher, Nifty holds 12900; IT, energy stocks surge

Pharma Reviews: Need to leverage medical value travel coupled with traditional systems of medicine: Director ...

Dr Sangita Reddy, President, FICCI said, “We believe that India has the capability of becoming the major global manufacturer in the healthcare sector.
Read more: Need to leverage medical value travel coupled with traditional systems of medicine: Director ...

US FDA News: FDA Approves First Drug to Treat Rare Metabolic Disorder

Today, the FDA approved the first treatment for primary hyperoxaluria type 1 (PH1), a rare genetic disorder which causes recurrent kidney stones and loss of kidney function.
Read more: FDA Approves First Drug to Treat Rare Metabolic Disorder

US FDA News: Coronavirus (COVID-19) Update: November 23, 2020

Coronavirus (COVID-19) Update, November 23, 2020
Read more: Coronavirus (COVID-19) Update: November 23, 2020

US FDA News: Fusion Health and Vitality Issues Voluntary Nationwide Recall of Core Essential Nutrients and Immune Boost Sublingual Vitamin D3 Due to the Unapproved Use of a Food Additive and Unapproved Marketing Statements

Fusion Health and Vitality LLC is voluntarily recalling all 2020 Lots of CORE essential nutrients and Immune Boost Sublingual Vitamin D3. CORE has been found to contain an unapproved food additive, hordenine HCl, rendering it adulterated. Immune Boost Labeling was found to contain statements that
Read more: Fusion Health and Vitality Issues Voluntary Nationwide Recall of Core Essential Nutrients and Immune Boost Sublingual Vitamin D3 Due to the Unapproved Use of a Food Additive and Unapproved Marketing Statements

US FDA News: FDA Expands Approval of Influenza Treatment to Post-Exposure Prevention

Today, the FDA expanded the approved indication for Xofluza (baloxavir marboxil) to include post-exposure prevention of influenza (flu) for patients 12 years of age and older after contact with an individual who has the flu.
Read more: FDA Expands Approval of Influenza Treatment to Post-Exposure Prevention

Pharma Reviews: HR Partnership for Enhanced Value Creation and Improved Experience in Healthcare Business

Giving the pharma industry point of view Farhat Umar, Sr VP – Group HR Head ... and made us realize the scope of Indian pharmaceutical companies.
Read more: HR Partnership for Enhanced Value Creation and Improved Experience in Healthcare Business

Pharma Reviews: Market LIVE: Sensex up 200 pts, Nifty tops 12900; IndusInd Bank extends gains

Shares of India's non-banking finance companies (NBFCs), especially those ... “The pharma sector is in focus and given its strong fundamentals and ...
Read more: Market LIVE: Sensex up 200 pts, Nifty tops 12900; IndusInd Bank extends gains

Pharma Reviews: Gland Pharma IPO investors made more than a billion dollars in just 2 days

This was the 13th company to list this year and the largest ever a public issue in the Indian pharma industry. Advertisement. The party may not be over ...
Read more: Gland Pharma IPO investors made more than a billion dollars in just 2 days

Pharma Reviews: Govt to provide industrial park facilities to grow API, pharma & nutraceutical industry

Indian pharma industry will continue to play a prominent role as the pharmacy of the world, the Chemicals and Fertilizers Ministry said in a statement.
Read more: Govt to provide industrial park facilities to grow API, pharma & nutraceutical industry

Pharma Reviews: Union Minister DV Sadananda Gowda says Government proactively looking to provide industrial ...

This way, he said, Indian pharma industry will continue to play a prominent ... “We are also encouraging innovation in pharmaceuticals and medical ...
Read more: Union Minister DV Sadananda Gowda says Government proactively looking to provide industrial ...

Pharma Reviews: Schott increases production capacity with Rs 220 cr investment

Schott Glass India has invested close to 219.8 crores on a melting tank ... supply of its high-quality pharma glass for the Indian pharma industry.
Read more: Schott increases production capacity with Rs 220 cr investment

US FDA News: Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19

Today, the FDA issued an emergency use authorization for two monoclonal antibodies to be administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients who are at high risk for progressing to severe COVID-19.
Read more: Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19

Pharma Reviews: Pharma firms see profit growth in Q2

Ahmedabad: The pharmaceutical industry has continued its growth ... Shah, senior vice-president, Indian Drug Manufacturers Association (IDMA).
Read more: Pharma firms see profit growth in Q2

Pharma Reviews: Indian pharma industry: Backbone of Indian economy in the current pandemic

The Indian pharma industry is known as 'the pharmacy of the world' as it is a leading supplier in generics with one of the highest numbers of USFDA ...
Read more: Indian pharma industry: Backbone of Indian economy in the current pandemic

Pharma Reviews: High demand, strict inspections — how Biden's presidency could impact India's pharma sector

High demand, strict inspections — how Biden's presidency could impact India's pharma sector. US is the biggest market for Indian pharmaceutical ...
Read more: High demand, strict inspections — how Biden's presidency could impact India's pharma sector

US FDA News: Coronavirus (COVID-19) Update: November 20, 2020

Coronavirus (COVID-19) Update
Read more: Coronavirus (COVID-19) Update: November 20, 2020

US FDA News: FDA Approves First Treatment for Hutchinson-Gilford Progeria Syndrome and Some Progeroid Laminopathies

Today, the U.S. Food and Drug Administration approved Zokinvy (lonafarnib) capsules to reduce the risk of death due to Hutchinson-Gilford Progeria Syndrome and for the treatment of certain processing-deficient progeroid laminopathies in patients one year of age and older.
Read more: FDA Approves First Treatment for Hutchinson-Gilford Progeria Syndrome and Some Progeroid Laminopathies

Pharma Reviews: Drugs & Cosmetics Act, 1940: Recommendations for a revamp

However, considering the ever-evolving regulatory requirements, industry ... Pharma manufacturers in the Indian market, supplying product to India ...
Read more: Drugs & Cosmetics Act, 1940: Recommendations for a revamp

US FDA News: Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss COVID-19 Vaccine Candidate

FDA has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10, 2020 to discuss Pfizer and BioNTech’s emergency use authorization request for a COVID-19 vaccine.
Read more: Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss COVID-19 Vaccine Candidate

Pharma Reviews: Stock Markets Live: Sensex erases losses, jumps over 300 points; RIL slips 2%

Warren Buffett's firm buying big into drug stocks. ... in a Covid windfall, analysts suggest Indian pharma isn't just a Covid theme, but beyond that.
Read more: Stock Markets Live: Sensex erases losses, jumps over 300 points; RIL slips 2%

Pharma Reviews: The Carrot and Stick Approach for Medical Device Manufacturing in India

The report also acknowledges that the medical device industry in India is just 1.4 % of the global market, a disproportionally smaller figure compared ...
Read more: The Carrot and Stick Approach for Medical Device Manufacturing in India

Pharma Reviews: Indian pharma's twin objectives in post Covid world: Boosting drug discovery and localising API ...

India's pharmaceutical sector also fulfills over half of the total global demand for vaccines. However, despite having a robust network of pharma ...
Read more: Indian pharma's twin objectives in post Covid world: Boosting drug discovery and localising API ...

Pharma Reviews: Covid vaccine should be available for public by April 2021: Serum Institute CEO

NEW DELHI: Vaccine maker Serum Institute of India's CEO Adar ... it far cheaper and more affordable than other vaccines we have in the market today," ... it will apply to the drug controller for emergency use authorisation in India.
Read more: Covid vaccine should be available for public by April 2021: Serum Institute CEO

Pharma Reviews: FOMO helps Gland Pharma swell on debut

This is the 13th company to list this year and the largest ever public issue in the Indian pharma industry. Advertisement. Gland Pharma total market cap ...
Read more: FOMO helps Gland Pharma swell on debut

US FDA News: Fresenius Kabi Issues Voluntary Nationwide Recall of a Single Lot of Dexmedetomidine Hydrochloride Injection Due to Cross-Contamination of Lidocaine

Fresenius Kabi USA is voluntarily recalling a single lot of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg/50 mL (4 mcg /mL), 50 mL fill in a 50 mL vial. Fresenius Kabi initiated this recall due to a trace amount of lidocaine present in the lot. This recall is being performed to the
Read more: Fresenius Kabi Issues Voluntary Nationwide Recall of a Single Lot of Dexmedetomidine Hydrochloride Injection Due to Cross-Contamination of Lidocaine

US FDA News: Coronavirus (COVID-19) Update: FDA Authorizes Drug Combination for Treatment of COVID-19

Today, the FDA issued an emergency use authorization for the drug baricitinib, in combination with remdesivir, for the treatment of COVID-19 in hospitalized adults and pediatric patients 2+ years requiring supplemental oxygen, invasive mechanical ventilation, or ECMO.
Read more: Coronavirus (COVID-19) Update: FDA Authorizes Drug Combination for Treatment of COVID-19

Pharma Reviews: Benchmark spending on healthcare should be around 8%: NITI aayog member Vinod Paul

... of E Pharma sector and ways to leverage it for Growth, Dr Rana Mehta Senior Partner and Healthcare Lead PWC said that Pharma Industry is India's ...
Read more: Benchmark spending on healthcare should be around 8%: NITI aayog member Vinod Paul

Pharma Reviews: Govt approves Rs 15000 cr to pharma sector to encourage local manufacturing of drugs

“The Indian pharmaceutical industry is the third largest in the world by volume and 14th largest in terms of value. It contributes 3.5% of the total drugs and ...
Read more: Govt approves Rs 15000 cr to pharma sector to encourage local manufacturing of drugs

Pharma Reviews: Stock Market Highlights: Market reverses gains, ends 1.3% lower; financials drag, SBI top loser

Stock Market Highlights: Indian shares ended with losses on Thursday after ... IT, Metal and Pharma indices also ended in the red for the day, down 0.5-1 percent. ... India's GDP growth will return to pre-COVID levels by Q1FY22, says ...
Read more: Stock Market Highlights: Market reverses gains, ends 1.3% lower; financials drag, SBI top loser

Pharma Reviews: KRChoksey: Pharma Sector Q2 Review - Another Good Quarter; Led By Exports And Cost Savings

Indian pharmaceutical market growth turns positive in September quarter; volume decline narrows: • For the quarter ended September 20, the Indian ...
Read more: KRChoksey: Pharma Sector Q2 Review - Another Good Quarter; Led By Exports And Cost Savings

Pharma Reviews: India, US partnership growing: Reifman

Hyderabad Pharma companies are global leaders in producing affordable low cost medicines and vaccines and can be a reliable partner for providing ...
Read more: India, US partnership growing: Reifman

US FDA News: FDA Releases New Outbreak Investigation Table

FDA releases new tool to communicate foodborne illness outbreak information frequently and as soon as the FDA begins an outbreak investigation.
Read more: FDA Releases New Outbreak Investigation Table

Pharma Reviews: Gland Pharma's grey market premium bounces back strongly ahead of stock market debut

The largest pharmaceutical initial public offering (IPO) that Indian markets have seen saw a tepid subscription with only Qualified Institutional Buyers ...
Read more: Gland Pharma's grey market premium bounces back strongly ahead of stock market debut

US FDA News: Coronavirus (COVID-19) Update: FDA Authorizes First COVID-19 Test for Self-Testing at Home

The FDA issued an emergency use authorization for the first COVID-19 diagnostic test that allows for self-collection and testing at home and provides test results in 30 minutes or less.
Read more: Coronavirus (COVID-19) Update: FDA Authorizes First COVID-19 Test for Self-Testing at Home

US FDA News: Coronavirus (COVID-19) Update: November 17, 2020

Coronavirus (COVID-19) Update
Read more: Coronavirus (COVID-19) Update: November 17, 2020

Pharma Reviews: 'Prepared To Cooperate With India On COVID-19 Vaccine': Xi Jinping At BRICS Summit

While Xi Jinping extended cooperation to India on the COVID vaccine, PM Modi highlighted the capability of the Indian pharma industry. Emphasizing ...
Read more: 'Prepared To Cooperate With India On COVID-19 Vaccine': Xi Jinping At BRICS Summit

Pharma Reviews: Nutrify India targets $130 million through I2C@46: a paradigm shift beyond traditions

Nutrify India is inviting all its 2500 members from pharma companies with an interest in nutraceuticals, Nutra companies to benefit from this as 20th ...
Read more: Nutrify India targets $130 million through I2C@46: a paradigm shift beyond traditions

US FDA News: COVID-19 Update: FDA’s Ongoing Commitment to Transparency for COVID-19 EUAs

FDA is committed to transparency around the EUA process
Read more: COVID-19 Update: FDA’s Ongoing Commitment to Transparency for COVID-19 EUAs

US FDA News: Coronavirus (COVID-19) Update: November 16, 2020

Coronavirus (COVID-19) Update
Read more: Coronavirus (COVID-19) Update: November 16, 2020

US FDA News: FDA Approves First Intratumoral Injection to Treat Non-Metastatic Mast Cell Tumors in Dogs

FDA approves first intratumoral injection to treat dogs with non-metastatic, skin-based (cutaneous) mast cell tumors (MCTs). The FDA is also approving Stelfonta to treat non-metastatic MCTs located under the dog’s skin (subcutaneous), in particular areas of a dog’s leg.
Read more: FDA Approves First Intratumoral Injection to Treat Non-Metastatic Mast Cell Tumors in Dogs

Pharma Reviews: Moderna says its vaccine is 94.5% effective in preventing Covid-19

Twin challenges for Indian pharma-boosting drug discovery and localising API production. Despite having a robust network of pharma companies and ...
Read more: Moderna says its vaccine is 94.5% effective in preventing Covid-19

Pharma Reviews: Twin challenges for Indian pharma-boosting drug discovery and localising API production

India's pharmaceutical sector also fuflfils over half of the total global demand for vaccines. However, despite having a robust network of pharma ...
Read more: Twin challenges for Indian pharma-boosting drug discovery and localising API production

Pharma Reviews: Four Indian drugmakers recall various products including Metformin Hydrochloride ER tablets in US

While Marksans Pharma is recalling diabetes drug, Zydus Pharmaceuticals (USA) is recalling drug which is used to reduce stomach acid. Similarly, ...
Read more: Four Indian drugmakers recall various products including Metformin Hydrochloride ER tablets in US

Pharma Reviews: Rakesh Jhunjhunwala believes tsunami of foreign funds incoming; PSUs could be next big winners?

Continuing his bullish views on the pharmaceutical industry, he said that India has the potential to be the pharma king of the world. India's API ...
Read more: Rakesh Jhunjhunwala believes tsunami of foreign funds incoming; PSUs could be next big winners?

Pharma Reviews: Indian drug firms recall various products in US market

New Delhi: Indian drug firms like Marksans Pharma, Aurobindo Pharma, Zydus and Jubilant are recalling products in the US market, as per the latest ...
Read more: Indian drug firms recall various products in US market

Pharma Reviews: Containing AMR contribution from pharmaceutical effluent involving multi-stakeholders: Dr Anita ...

In India and China, the burden of the effluent from pharmaceutical effluent is higher than in other countries as 80%-90% of the antibiotics sold ...
Read more: Containing AMR contribution from pharmaceutical effluent involving multi-stakeholders: Dr Anita ...

Pharma Reviews: Indian drug firms recall various products in US market

While Marksans Pharma is recalling diabetes drug, Zydus Pharmaceuticals (USA) is recalling drug which is used to reduce stomach acid. Agencies ...
Read more: Indian drug firms recall various products in US market

Pharma Reviews: Share Market LIVE: Diwali Muhurat trading to begin soon; Sensex, Nifty look to continue ...

A slew of measures have been announced that could help India's pharmaceutical industry emerge as a global player. Domestic pharma players have ...
Read more: Share Market LIVE: Diwali Muhurat trading to begin soon; Sensex, Nifty look to continue ...

US FDA News: Coronavirus (COVID-19) Update: November 13, 2020

Coronavirus (COVID-19) Update
Read more: Coronavirus (COVID-19) Update: November 13, 2020

Pharma Reviews: ICICI Bank, Infosys among top Diwali picks by HDFC Securities

Fourth largest player with 4.2 per cent market share in Indian pharmaceutical market. It derives major part of domestic revenues from high growth ...
Read more: ICICI Bank, Infosys among top Diwali picks by HDFC Securities

Pharma Reviews: Heads up! IT, Healthcare are likely to make the most from Joe Biden's victory in US elections

Further, Biden's focus on affordable healthcare with generic drugs creates optimism for Indian pharma companies, given India's global leadership ...
Read more: Heads up! IT, Healthcare are likely to make the most from Joe Biden's victory in US elections

Pharma Reviews: Stock Market Live: Sensex in green, Nifty around 12700 amid volatility; pharma stocks gain, banks ...

Stock Market Live: The Indian equity benchmark indices, Sensex and Nifty traded flat amid volatility Friday amid weak global cues as rising pandemic ...
Read more: Stock Market Live: Sensex in green, Nifty around 12700 amid volatility; pharma stocks gain, banks ...

US FDA News: Coronavirus (COVID-19) Update: November 12, 2020

Coronavirus (COVID-19) Update
Read more: Coronavirus (COVID-19) Update: November 12, 2020

Pharma Reviews: CM's pharma cargo push at MPT just a pipe dream: Stakeholders

Goa has around 75 licenced pharmaceutical manufacturing units and the state accounts for 11% of India's pharma exports. Gaskell said that due to the ...
Read more: CM's pharma cargo push at MPT just a pipe dream: Stakeholders

US FDA News: Cook Medical Recalls Fixed Core Wire Guides, Due to Device Damage from a Manufacturing Error

The Cook Fixed Core Wire Guide is a curved wire guide made of stainless steel with non-reactive coating and helps insert medical devices into the body.
Read more: Cook Medical Recalls Fixed Core Wire Guides, Due to Device Damage from a Manufacturing Error

Pharma Reviews: 18 generic drug makers will work with Medicines Patent Pool to accelerate global access to Covid ...

New Delhi: With coronavirus infections surging worldwide, 18 generic pharmaceutical manufacturers have pledged to work with a non-profit ...
Read more: 18 generic drug makers will work with Medicines Patent Pool to accelerate global access to Covid ...

Pharma Reviews: Govt allots R&D grant of Rs 900 crores for COVID-19 vaccine development

Nirmala Sitharaman, Finance Minister of India, announcing the details of the third stimulus package, informed that Rs 900 crores would be provided for ...
Read more: Govt allots R&D grant of Rs 900 crores for COVID-19 vaccine development

Pharma Reviews: Market LIVE: Banks drag Sensex 200 pts to day's low; FM unveils new measures

Profits at Indian companies have rebounded from the worst decline in at ... Drug firm Zydus Cadila on Thursday said it has successfully completed a ...
Read more: Market LIVE: Banks drag Sensex 200 pts to day's low; FM unveils new measures

Pharma Reviews: Why investors need to be overweight on pharma

Overall, the competitive intensity has reduced globally and in the largest US generic market and Indian pharma companies have gained a lot of ...
Read more: Why investors need to be overweight on pharma

Pharma Reviews: As Centre extends Rs 1.46 lakh cr PLI Scheme, Morgan Stanley says manufacturing pie in India ...

Pharmaceuticals drugs: Indian pharma industry is 3rd and 14th largest globally by volume and value, respectively. Indian pharma contributes to 3.5% ...
Read more: As Centre extends Rs 1.46 lakh cr PLI Scheme, Morgan Stanley says manufacturing pie in India ...

Pharma Reviews: Indian Covid vaccine could come before AstraZeneca's

Chinese firm Tibet Rhodiola Pharma holding said on Wednesday that it has obtained non-exclusive right to develop, manufacture, import or ...
Read more: Indian Covid vaccine could come before AstraZeneca's

Pharma Reviews: Kunnath Pharmaceuticals launches antiviral herbal product across India

The company is spending over Rs 100 crore in research and development and on the new products, Kunnath Pharmaceuticals in a statement. "We are ...
Read more: Kunnath Pharmaceuticals launches antiviral herbal product across India

Pharma Reviews: The institute is introducing course essential for developing Medical Devices: NIPER

... expressed that bright pharmaceutical professionals will have a pivotal role in the health care industry globally. In this regard, Indian Pharmaceutical ...
Read more: The institute is introducing course essential for developing Medical Devices: NIPER

Pharma Reviews: SCHOTT opens new glass melting tank in Gujarat with €25M investment

SCHOTT AG, a global leader in pharmaceutical glass manufacturing, has ... supply of its high-quality pharma glass for the Indian pharma industry.
Read more: SCHOTT opens new glass melting tank in Gujarat with €25M investment

Pharma Reviews: Here are the Top News Stories 11th November 2020

The Indian pharmaceutical industry is the third largest in the world by volume and 14th largest in terms of value. It contributes 3.5% of the total drugs ...
Read more: Here are the Top News Stories 11th November 2020

Pharma Reviews: Respect territorial integrity, PM tells SCO as Xi listens

He mentioned that India's brave soldiers participated in about 50 UN peacekeeping missions and the country's pharma industry was supplying ...
Read more: Respect territorial integrity, PM tells SCO as Xi listens

Pharma Reviews: Stock Market Live: Sensex trades higher, Nifty above 12700; pharma, metal stocks lead

Stock Market Live: Indian equity indices, Sensex and Nifty were trading higher amid volatility on Wednesday afternoon. Gains in pharma, metals, ...
Read more: Stock Market Live: Sensex trades higher, Nifty above 12700; pharma, metal stocks lead

Pharma Reviews: SCHOTT Glass India inaugurates new glass melting tank at Gujarat facility

Our Indian facility is an integral part of our pledge to cater to any requirement of the pharma industry in a sustainable manner,” said Dr Patrick ...
Read more: SCHOTT Glass India inaugurates new glass melting tank at Gujarat facility

Pharma Reviews: Pharma sector's stellar show in CY20 likely to extend further, say experts

The pharma sector remained among the few sectors that continued its ... The Indian pharma industry has steadily evolved over the years and now ...
Read more: Pharma sector's stellar show in CY20 likely to extend further, say experts

Pharma Reviews: India expects full support from SCO for reformed multilateralism: PM Modi

... Indian pharma industry supplied essential medicines to over 150 countries. ... Mr Modi reiterated India's firm belief in regional peace, security and ...
Read more: India expects full support from SCO for reformed multilateralism: PM Modi

Pharma Reviews: India-made Covid-19 vaccine could be launched as early as February: Government scientist

... technologies as the pharma industry. With Contract Research and Manufacturing Services (CRAMs) gaining traction, India has emerged as a global ...
Read more: India-made Covid-19 vaccine could be launched as early as February: Government scientist

Pharma Reviews: Evening News

Mr Modi reiterated India's firm belief in regional peace, security and ... Indian pharma industry supplied essential medicines to over 150 countries.
Read more: Evening News

Pharma Reviews: 'Respect others' sovereignty, territorial integrity': PM Modi's stern message to Pak, China at 20th ...

Speaking about the coronavirus crisis, PM Modi said that India's pharma industry sent essential medicines to over 150 countries, adding that the ...
Read more: 'Respect others' sovereignty, territorial integrity': PM Modi's stern message to Pak, China at 20th ...

US FDA News: Coronavirus (COVID-19) Update: November 10, 2020

Coronavirus (COVID-19) Update
Read more: Coronavirus (COVID-19) Update: November 10, 2020

US FDA News: FDA Encourages Manufacturers to Clearly Declare All Uses of Sesame in Ingredient List on Food Labels

FDA has issued a draft guidance encouraging food manufacturers to voluntarily declare sesame in the ingredient list on food labels. While most products declare sesame as an ingredient, there are times when sesame is not required to be declared, such as in flavors and spices.
Read more: FDA Encourages Manufacturers to Clearly Declare All Uses of Sesame in Ingredient List on Food Labels

Pharma Reviews: 14th Foundation Day Celebrations at National Institute of Pharmaceutical Education and Research ...

In this regard, Indian Pharmaceutical Institutes and Industries have played a vital and critical role in the global pharma market and pointed out the ...
Read more: 14th Foundation Day Celebrations at National Institute of Pharmaceutical Education and Research ...

Pharma Reviews: India expects full support from SCO for reformed multilateralism that reflects today's global realities ...

The Prime Minister said, during the difficult times of pandemic, Indian pharma industry supplied essential medicines to over 150 countries. As the ...
Read more: India expects full support from SCO for reformed multilateralism that reflects today's global realities ...

Pharma Reviews: We should respect sovereignty and territorial integrity: PM Modi's message to China, Pakistan at ...

In this difficult time of unprecedented epidemic, India's pharma industry sent essential medicines to over 150 countries, he said. More from the section.
Read more: We should respect sovereignty and territorial integrity: PM Modi's message to China, Pakistan at ...

Pharma Reviews: PM Modi LIVE Updates: Everyone needs to move forward while respecting territorial integrity, says ...

In this difficult time of unprecedented epidemic, India's pharma industry sent essential medicines to over 150 nations: PM Modi at SCO summit.
Read more: PM Modi LIVE Updates: Everyone needs to move forward while respecting territorial integrity, says ...

Pharma Reviews: Breaking news live updates: PM Modi addresses SCO Summit

In this very difficult time of unprecedented epidemic, India's pharma industry has sent essential medicines to more than 150 countries. As the world's ...
Read more: Breaking news live updates: PM Modi addresses SCO Summit

Pharma Reviews: Gland Pharma IPO gets slow response, subscribed 6% so far on day 2; grey market premium falls

India's biggest pharma IPO, Gland Pharma attracted 6 per cent bids on the second day of the bidding process so far. Even as Indian share market is ...
Read more: Gland Pharma IPO gets slow response, subscribed 6% so far on day 2; grey market premium falls

Pharma Reviews: Granules India board clears proposal to set up subsidiary in Hyderabad

New Delhi: Drug firm Granules India on Monday said its board has ... to incorporate a wholly-owned subsidiary of the company in Hyderabad, India to ...
Read more: Granules India board clears proposal to set up subsidiary in Hyderabad

Pharma Reviews: India will need 6 crore vials for Covid-19 shots in first 6 months

... around 6.10 crore glass vials to pack Covid-19 vaccines for the first six months once a vaccine is available and pharma companies developing the ...
Read more: India will need 6 crore vials for Covid-19 shots in first 6 months

Pharma Reviews: Covid-dictated shift to preventive health, nutraceuticals ready to take the next leap in India

An EY report says that India's agri-tech industry has the potential to touch ... In terms of facilities, the country has more than 3,000 pharma companies ...
Read more: Covid-dictated shift to preventive health, nutraceuticals ready to take the next leap in India

US FDA News: Coronavirus (COVID-19) Update: November 9, 2020

Coronavirus (COVID-19) Update
Read more: Coronavirus (COVID-19) Update: November 9, 2020

Pharma Reviews: Biden's focus on Obamacare positive for Indian pharma, but friction on patents, price controls to ...

The Indian pharmaceutical industry sees US President-elect Joe Biden's proposed plan to expand Obamacare, bring more competition and reduce ...
Read more: Biden's focus on Obamacare positive for Indian pharma, but friction on patents, price controls to ...

Pharma Reviews: Indian demand for Covid-19 drug remdesivir rising sharply - Cipla

India's pharmaceutical companies hope Biden will not push for 'Made in America' drugs. The industry is closely watching what stance the president elect ...
Read more: Indian demand for Covid-19 drug remdesivir rising sharply - Cipla

US FDA News: Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibody for Treatment of COVID-19

Today, the FDA issued an emergency use authorization for the investigational monoclonal antibody therapy bamlanivimab for the treatment of mild-to-moderate COVID-19 in adult and pediatric patients.
Read more: Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibody for Treatment of COVID-19

US FDA News: Lohxa LLC Issues Voluntary Nationwide Recall of Chlorhexidine Gluconate Oral Rinse USP, 0.12% Due to Microbial Contamination

Lohxa, LLC is voluntarily recalling Chlorhexidine Gluconate Oral Rinse USP, 0.12% Alcohol free (NDC:70166-027-15) products bearing an expiration date from 01/31/21 – 03/31/21 (see specific lots below) to the consumer level. This product is sourced and repackaged from Sunstar Americas Inc. who has no
Read more: Lohxa LLC Issues Voluntary Nationwide Recall of Chlorhexidine Gluconate Oral Rinse USP, 0.12% Due to Microbial Contamination

US FDA News: Stryker Neurovascular Recalls Trevo XP ProVue Retriever Due to Core Wire That May Break or Separate During Use

Stryker Neurovascular Recalls Trevo XP ProVue Retriever Due to Core Wire That May Break or Separate During Use
Read more: Stryker Neurovascular Recalls Trevo XP ProVue Retriever Due to Core Wire That May Break or Separate During Use

US FDA News: FDA Offers Guidance to Enhance Diversity in Clinical Trials, Encourage Inclusivity in Medical Product Development

The FDA has issued final guidance which provides the agency’s current thinking on steps to broaden eligibility criteria in clinical trials through inclusive trial practices. The guidance provides recommendations for how to increase enrollment of underrepresented populations in clinical trials.
Read more: FDA Offers Guidance to Enhance Diversity in Clinical Trials, Encourage Inclusivity in Medical Product Development

Pharma Reviews: Global stocks hit record highs after Biden wins US presidency in historic vote, but political ...

China's Fosun-owned Gland Pharma IPO opens today— Here's all you need to know about India's largest pharmaceutical IPO. Navdeep Yadav. Nov 9, ...
Read more: Global stocks hit record highs after Biden wins US presidency in historic vote, but political ...

Pharma Reviews: China's Fosun-owned Gland Pharma IPO opens — Here's all you need to know about India's ...

Gland Pharma has a successful track record of operating a B2B model with leading pharmaceutical companies such as Sagent Pharmaceuticals and ...
Read more: China's Fosun-owned Gland Pharma IPO opens — Here's all you need to know about India's ...

Pharma Reviews: 5 ways Biden's economic policies are different from Trump's

The usual Democrat bias of larger healthcare spending might be a tailwind for the pharmaceuticals industry at large, including for Indian pharma ...
Read more: 5 ways Biden's economic policies are different from Trump's

Pharma Reviews: Bidencare boost for desi pharma companies

MUMBAI: The Indian pharma sector is expected to benefit from the Biden presidency on the back of an increased push for generic prescriptions and ...
Read more: Bidencare boost for desi pharma companies

Pharma Reviews: Pandemic opened up new opportunities for Indian Biotech sector: Kiran Mazumdar Shaw

The Founder Chairperson said that a large number of companies, including our own, have developed essential drugs that can actually manage the ...
Read more: Pandemic opened up new opportunities for Indian Biotech sector: Kiran Mazumdar Shaw

Pharma Reviews: Joe Biden's business plan and what it means for India

Pharma sector may gain with increased government spending on healthcare. The visa regime will may not see big changes, but IT companies can ...
Read more: Joe Biden's business plan and what it means for India

Pharma Reviews: Gland Pharma IPO opens today I Here is in depth analysis of the issue

The company follows a diversified B2B-led model across markets globally, complemented by a targeted B2C model in India. The US accounts for 67% of ...
Read more: Gland Pharma IPO opens today I Here is in depth analysis of the issue

Pharma Reviews: China's Expansion In Pharma Industry Spells Trouble For India And Developing Nations

Cipla, Lupin, Dr. Reddy's Laboratories, Aurobindo Pharma, and Sun Pharmaceutical Industries are some names of India's top pharmaceutical firms.
Read more: China's Expansion In Pharma Industry Spells Trouble For India And Developing Nations

Pharma Reviews: China's Expansion In Pharma Industry Spells Trouble For India And Developing Nations

Indian pharmaceutical industry is third largest in the world by volume and 14th largest by value. It is known for selling medicines at reasonable and ...
Read more: China's Expansion In Pharma Industry Spells Trouble For India And Developing Nations

Pharma Reviews: What's ahead under President Joe Biden, industry by industry

MEDICAL TECHNOLOGY: Biden plans to double down on testing to help control the coronavirus outbreak, bolstering drive-through sites, investing in ...
Read more: What's ahead under President Joe Biden, industry by industry

Pharma Reviews: Biocon Biologics gets Rs 1125 cr capital infusion from Goldman Sachs

The company is confident of achieving aspiration of serving 5 million ... be a major global player in this dynamic segment of the pharmaceutical industry, ... making it the only company from India to enable affordable access to three ...
Read more: Biocon Biologics gets Rs 1125 cr capital infusion from Goldman Sachs

Pharma Reviews: Gland Pharma raises Rs 1944 crore from anchor investors ahead of IPO

This could probably be the first big Indian company with a Chinese parent to go for public listing. The company''s promoters are Fosun Singapore and ...
Read more: Gland Pharma raises Rs 1944 crore from anchor investors ahead of IPO

Pharma Reviews: India's pharma industry is facing challenges from China – and it's bad news for developing nations

India's top pharma firms include Cipla, Aurobindo Pharma, Lupin, Dr Reddy's Laboratories and Sun Pharmaceutical Industries. One challenge is coming ...
Read more: India's pharma industry is facing challenges from China – and it's bad news for developing nations

Pharma Reviews: To boost pharma investments, Modi govt sets up panel to revamp policies & draw up action plan

Krishna Reddy, president, Bull Drug Manufacturers of India; and Sudarshan Jain, secretary-general, Indian Pharmaceutical Alliances (IPA). Dr Sumit ...
Read more: To boost pharma investments, Modi govt sets up panel to revamp policies & draw up action plan

Pharma Reviews: Lupin reports cybersecurity breach, COVID-19 makes pharma firms more vulnerable

Indian pharmaceutical company Lupin is the latest victim of a cyber attack. ... “It must be recognized as a big threat to pharma companies of India ...
Read more: Lupin reports cybersecurity breach, COVID-19 makes pharma firms more vulnerable

Pharma Reviews: The Pandemic has provided the industry to recalibrate and leverage the use of digital technologies ...

Indian-manufactured generics and other drugs have significantly contributed to the growth of the Indian pharmaceutical industry through the decades ...
Read more: The Pandemic has provided the industry to recalibrate and leverage the use of digital technologies ...

Pharma Reviews: US presidential election results may not impact Indian pharma industry

The prime reason is while the US, just like other countries, is trying to lessen dependence on imports for essential drugs, the Indian industry feels they ...
Read more: US presidential election results may not impact Indian pharma industry

Pharma Reviews: Covid opens pharma firms to threats: Lupin reports cyber attack

Several industry executives told The Indian Express on Friday that while ... Indian pharma companies, currently plugged into the global supply chain ...
Read more: Covid opens pharma firms to threats: Lupin reports cyber attack

US FDA News: FDA Permits Marketing of New Device Designed to Reduce Sleep Disturbance Related to Nightmares in Certain Adults

FDA has permitted marketing of a new device intended for the temporary reduction of sleep disturbance related to nightmares in adults 22 years or older who suffer from nightmare disorder or have nightmares from post-traumatic stress disorder (PTSD).
Read more: FDA Permits Marketing of New Device Designed to Reduce Sleep Disturbance Related to Nightmares in Certain Adults

US FDA News: Coronavirus (COVID-19) Update: FDA Authorizes First Test that Detects Neutralizing Antibodies from Recent or Prior SARS-CoV-2 Infection

Today, the U.S. Food and Drug Administration authorized the first serology test that detects neutralizing antibodies from recent or prior SARS-CoV-2 infection.
Read more: Coronavirus (COVID-19) Update: FDA Authorizes First Test that Detects Neutralizing Antibodies from Recent or Prior SARS-CoV-2 Infection

Pharma Reviews: India is a key market for us, it is a pharma centre of excellence

... Regional Business Director, Corning Reactor Technologies talks about Advanced-Flow Reactors (AFR) and explains how it can help Indian pharma ...
Read more: India is a key market for us, it is a pharma centre of excellence

Pharma Reviews: In chat with Anil Singhvi today, IIFL's Nirmal Jain says every crisis gives good opportunity to investors

Pharmaceutical and Healthcare sector will see good growth due to ... Indian Pharma companies have been boon to the U.S. market during tough times ...
Read more: In chat with Anil Singhvi today, IIFL's Nirmal Jain says every crisis gives good opportunity to investors

US FDA News: FDA Takes Efforts to Protect Patients from Potentially Harmful Compounded Drugs Through Finalizing Insanitary Conditions Guidance

FDA is releasing a final guidance to help compounders identify and prevent insanitary conditions at facilities. The guidance provides recent examples of insanitary conditions and details corrective actions that facilities should take when they identify these conditions.
Read more: FDA Takes Efforts to Protect Patients from Potentially Harmful Compounded Drugs Through Finalizing Insanitary Conditions Guidance

Pharma Reviews: Three things to know for Teji Mandi investors on November 6, 2020

Indian market would welcome Joe Biden's victory as he is expected to be more ... The cement industry is witnessing steady underlying demand. ... API (Active Pharma Ingredients) and smartphone manufacturing in India in those ...
Read more: Three things to know for Teji Mandi investors on November 6, 2020

Pharma Reviews: Dr Reddy's Labs, Cadila Healthcare, Alkem Labs, Cipla to IPCA Labs, all you need to know about ...

India Pharma market, a pit stop before a smooth run: Indian pharmaceutical market (IPM) sales were impacted by the Covid-19 lockdown in Apr-May ...
Read more: Dr Reddy's Labs, Cadila Healthcare, Alkem Labs, Cipla to IPCA Labs, all you need to know about ...

Pharma Reviews: Diwali picks: Brokerages expect these 18 stocks to be in action during Samvat 2077

... down 10.5 percent QoQ) due to industry wide slowdown in Indian Pharma Market (IPM) in the months of April & May, though recovery was seen in ...
Read more: Diwali picks: Brokerages expect these 18 stocks to be in action during Samvat 2077

Pharma Reviews: Govt to soon launch self-certification scheme for chemicals industry: Mansukh Mandaviya

Global companies are today investing in India," he added. ... Incentive (PLI) scheme in the chemicals sectors as we have done in the pharma sector," ...
Read more: Govt to soon launch self-certification scheme for chemicals industry: Mansukh Mandaviya

Pharma Reviews: B'desh signs agreement with Serum Institute of India, Beximco Pharmaceuticals for corona vaccine

... Serum Institute of India and Beximco Pharmaceuticals Ltd, a pharmaceutical company in Bangladesh, for coronavirus vaccine developed by Oxford.
Read more: B'desh signs agreement with Serum Institute of India, Beximco Pharmaceuticals for corona vaccine

Pharma Reviews: Gland Pharma launches Rs 6500 crore largest pharma IPO in India, offer opens Nov 9

Hyderabad: In the largest IPO by a pharmaceutical company in India, Hyderabad-based Gland Pharma Ltd's Rs 6,000 crore Initial Public Offer (IPO) is ...
Read more: Gland Pharma launches Rs 6500 crore largest pharma IPO in India, offer opens Nov 9

Pharma Reviews: ED asks Gland Pharma to transfer 6 million shares held by Ramalinga Raju to escrow account

This is one of the largest IPOs in India's pharmaceutical sector. The firm has set a price band of Rs 1,490-1,500 per share (face value of Re 1). At least 10 ...
Read more: ED asks Gland Pharma to transfer 6 million shares held by Ramalinga Raju to escrow account

Pharma Reviews: Top stocks for Diwali 2020 : ICICI Sec's five Muhurat picks, up to 30% upside

A prominent Indian pharma company catering to 80+ markets with a global portfolio of 1500+ products. With 46 manufacturing facilities spread globally ...
Read more: Top stocks for Diwali 2020 : ICICI Sec's five Muhurat picks, up to 30% upside

Pharma Reviews: Meet Panjab University teachers ranked among top scientists

She has worked to enhance bio-performance of drugs and plant extracts. Honours: The UIPS chairperson is also Indian Pharmaceutical Association's ...
Read more: Meet Panjab University teachers ranked among top scientists

Pharma Reviews: Sensex, Nifty rise as IT stocks gain on stronger dollar

BENGALURU - Indian shares rose for a third consecutive session on ... Drugmaker Sun Pharmaceutical Industries rose nearly 5% after the company ...
Read more: Sensex, Nifty rise as IT stocks gain on stronger dollar

Pharma Reviews: Making API production cost effective with technology

India contributes a grand share in global generic market up to 50% as per recent market survey. In US alone, Indian Pharma sector has bagged more ...
Read more: Making API production cost effective with technology

Pharma Reviews: Stock Market Highlights: Sensex ends 355 points higher, Nifty above 11900; IT, pharma stocks lead

Stock Market Highlights: Indian indices ended higher led by gains in pharma and IT stocks as a close US presidential election pushed the dollar ...
Read more: Stock Market Highlights: Sensex ends 355 points higher, Nifty above 11900; IT, pharma stocks lead

US FDA News: Coronavirus (COVID-19) Update: November 3, 2020

Coronavirus (COVID-19) Update
Read more: Coronavirus (COVID-19) Update: November 3, 2020

Pharma Reviews: Telangana, front runner in life sciences

Hyderabad: Telangana's pharmaceuticals industry currently stands at around $12 billion. Hyderabad accounts for almost 40 per cent of India's total ...
Read more: Telangana, front runner in life sciences

US FDA News: Potential for False Positive Results with Antigen Tests for Rapid Detection of SARS-CoV-2 - Letter to Clinical Laboratory Staff and Health Care Providers

Laboratories should expect some false positive results when screening large populations with a low prevalence of COVID-19 infection.
Read more: Potential for False Positive Results with Antigen Tests for Rapid Detection of SARS-CoV-2 - Letter to Clinical Laboratory Staff and Health Care Providers

Pharma Reviews: What Will Be the Impact of the US Election on the Indian Economy and India-US Ties?

These factors have a direct impact on sectors like IT, auto and pharmaceuticals. But on a macro scale, all sectors' exposure to India-US ties hinge on ...
Read more: What Will Be the Impact of the US Election on the Indian Economy and India-US Ties?

US FDA News: Medtronic Recalls Rashkind Balloon Septostomy Catheters for Quality Issues

Medtronic Recalls Rashkind Balloon Septostomy Catheters for Quality Issues
Read more: Medtronic Recalls Rashkind Balloon Septostomy Catheters for Quality Issues

US FDA News: Nostrum Laboratories, Inc. Issues Voluntary Nationwide Recall of Metformin HCl Extended Release Tablets, USP 500 mg, Due to N-Nitrosodimethylamine (NDMA) Content Above the Acceptable Daily Intake (ADI) Limit

Nostrum Laboratories, Inc. is voluntarily recalling 2 (two) lots of Metformin HCl Extended Release Tablets, USP 500 mg to the consumer level. The Metformin HCl Extended Release Tablets, USP 500 mg have been found to contain levels of nitrosamine impurities above the ADI limit of 96 ng/day as publish
Read more: Nostrum Laboratories, Inc. Issues Voluntary Nationwide Recall of Metformin HCl Extended Release Tablets, USP 500 mg, Due to N-Nitrosodimethylamine (NDMA) Content Above the Acceptable Daily Intake (ADI) Limit

Pharma Reviews: Govt repeats warning to pharma firms, says don't 'promote products in unethical ways'

The letter is addressed to organisations that constitute the drug maker lobby, including the Indian Drug Manufacturers Association (IDMA), the Indian ...
Read more: Govt repeats warning to pharma firms, says don't 'promote products in unethical ways'

Pharma Reviews: India is looking to secure 600 million doses of the Covid-19 vaccine by leveraging its ...

India has leveraged its manufacturing capacity to pre-order 600 million doses of potential Covid-19 vaccine and negotiating for another billion doses, ...
Read more: India is looking to secure 600 million doses of the Covid-19 vaccine by leveraging its ...

Pharma Reviews: US Elections and how it will impact gold and stocks

The pharma industry would hope for a Biden victory since they believe that it would make life a lot simpler for Indian pharma companies.
Read more: US Elections and how it will impact gold and stocks

Pharma Reviews: Stock Market Live: Sensex jumps over 400 points, Nifty above 11800; banks lead, ICICI Bank top ...

Stock Market Live: Indian shares were trading higher on Tuesday tracking a ... In comparison, the Nifty Pharma index was up 40 percent and the ...
Read more: Stock Market Live: Sensex jumps over 400 points, Nifty above 11800; banks lead, ICICI Bank top ...

Pharma Reviews: Stocks To Watch: Adani Enterprises, Hindalco, NTPC, Vedanta, Sun Pharma, Zee

The target company belongs to optical telecommunications industry. ... Ajanta Pharma; Alembic; CARE Ratings; Dabur India; Deepak Fertilizers and ...
Read more: Stocks To Watch: Adani Enterprises, Hindalco, NTPC, Vedanta, Sun Pharma, Zee

US FDA News: Nostrum Laboratories, Inc. Issues Voluntary Nationwide Recall of Metformin HCl Extended Release Tablets, USP 750 mg, Due to N-Nitrosodimethylamine (NDMA) Content Above the Acceptable Daily Intake (ADI) Limit

Kansas City, Missouri, Nostrum Laboratories, Inc. is voluntarily recalling 2 (two) lots of Metformin HCl Extended Release Tablets, USP 750 mg to the consumer level. The Metformin HCl Extended Release Tablets, USP 750 mg have been found to contain levels of nitrosamine impurities above the ADI limit
Read more: Nostrum Laboratories, Inc. Issues Voluntary Nationwide Recall of Metformin HCl Extended Release Tablets, USP 750 mg, Due to N-Nitrosodimethylamine (NDMA) Content Above the Acceptable Daily Intake (ADI) Limit

Pharma Reviews: India's largest pharma IPO set to hit market

This will be the largest IPO by a pharmaceutical company in India. The biggest IPO till date in the sector was from Eris Lifesciences, which raised Rs ...
Read more: India's largest pharma IPO set to hit market

Pharma Reviews: Reducing API dependence: Have we got the strategy right?

China is considerably enhancing its presence in the global generic drug market, a challenge to the Indian pharma industry. During the last ten years, ...
Read more: Reducing API dependence: Have we got the strategy right?

Pharma Reviews: DoP issues letter to pharma associations to ensure adherence to UCPMP

The Department of Pharmaceutical (DoP) has issued a letter to the pharma industry's key ... in 2014 as a code of marketing practices for the Indian pharma industry, remains a voluntary exercise to be adopted by pharma companies.
Read more: DoP issues letter to pharma associations to ensure adherence to UCPMP

Pharma Reviews: Amid the COVID-19 pandemic, Indian pharma is being squeezed

India's pharmaceutical industry is renowned for selling medicines to the world at reasonable prices, especially developing countries. This has helped ...
Read more: Amid the COVID-19 pandemic, Indian pharma is being squeezed